On the one hand, these cells can kill cancer cells via ROS and neutrophil elastase, induce apoptosis through TRAIL, inhibit angiogenesis through VEGF-A165b, and enhance T-cell immune responses upon TGF-β inhibition. This evidence concerns the gene TGFB1 and cancer.